274 related articles for article (PubMed ID: 1331538)
1. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
Cohen JI; Wang F; Kieff E
J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
[TBL] [Abstract][Full Text] [Related]
3. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
Harada S; Yalamanchili R; Kieff E
J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
[TBL] [Abstract][Full Text] [Related]
4. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
Robertson ES; Tomkinson B; Kieff E
J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
[TBL] [Abstract][Full Text] [Related]
5. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Tong X; Yalamanchili R; Harada S; Kieff E
J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus recombinants from overlapping cosmid fragments.
Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen JI; Wang F; Mannick J; Kieff E
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
[TBL] [Abstract][Full Text] [Related]
8. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.
Robertson E; Kieff E
J Virol; 1995 Feb; 69(2):983-93. PubMed ID: 7815566
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
[TBL] [Abstract][Full Text] [Related]
11. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
Hu LF; Minarovits J; Cao SL; Contreras-Salazar B; Rymo L; Falk K; Klein G; Ernberg I
J Virol; 1991 Mar; 65(3):1558-67. PubMed ID: 1847471
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
13. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
Ling PD; Ryon JJ; Hayward SD
J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
[TBL] [Abstract][Full Text] [Related]
14. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
18. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
Contreras-Salazar B; Klein G; Masucci MG
J Virol; 1989 Jun; 63(6):2768-72. PubMed ID: 2542588
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
20. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]